A News

Agilent announces second quarter earnings.

Thank you, Jodi, and welcome everyone to Agilent's conference call for the second quarter of fiscal year 2020. On the webcast today are Mike McMullen, Agilent's President and CEO; and Bob McMahon, Agilent's Senior Vice President and CFO. Joining for the Q&A after prepared remarks will be Jacob Thaysen, President of Agilent's Life Science and Applied Markets Group; and Sam Raha, President of Agilent's Diagnostics and Genomics Group, along with Padraig McDonnell, President of the Agilent CrossLab Group.

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Agilent Technologies, Inc. New York, May 15, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Agilent Technologies, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

Soon you’ll need to wear a face covering if you want to ride in an Uber.Read more...

America’s jigsaw puzzle consumption has increased wildly in the era of physical distancing. People stuck indoors with nothing to do have turned to tiny, brightly colored, irregularly shaped slices of cardboard to provide them with a sense of control over a ch…

In the event that your pet needs medical care, what do you do? As with so many other aspects of life during a pandemic, getting veterinary care for your pet is a rapidly changing situation, one for which vets across the country have adapted. Read more...

This week, the New York Times introduced many of us to the “murder hornet,” more accurately known as the Asian giant hornet. But a small subset of us were already familiar with this bug, because we’d eaten it.Read more...

Agilent (A) delivered earnings and revenue surprises of 22.41% and 5.23%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?

If you’ve been furloughed during the coronavirus pandemic, you might be asking yourself whether it’s better to wait it out or whether you need to start looking for another job. Read more...

The U.S. death toll from the coronavirus that causes COVID-19 edged closer to 100,000 on Friday, as the news emerged that the Centers for Disease Control and Prevention has been combining the results of two different types of tests for the illness in a move that has been sharply criticized by health experts.

When you see a flat line on a graph, it’s tempting to think, “Oh hey, at least the situation isn’t getting any worse!” But one of the common types of charts we see for COVID-19 is of new cases per day. In that case, a flat line means that things are, in fact,…

The U.S. death toll from the coronavirus that causes COVID-19 rose above 71,000 on Wednesday, as President Donald Trump appeared to back off his announcement that he would phase out the government task force created to manage the pandemic

Agilent's (A) fiscal second-quarter results are likely to reflect the global coronavirus-driven economic crisis.

Custom Zoom backgrounds prevent you from having to show off the same boring wall, messy apartment or kid-caused chaos in every meeting. And if you grew up on BBC shows like “Doctor Who,” “EastEnders,” and “BlackAdder,” you can now bring nostalgia to your conf…

The litter box. If you are a cat owner—especially if you have cats who seem to poop half their body weight daily, such as mine do—the foul rectangle inspires a particular sense of unease. Cleaning it is the task every cat owner dreads. This need not be the ca…

The tuna sandwich will never go out of style, because it was never stylish to begin with. It’s humble, even homely, yet intensely comforting and nostalgic. Tuna salad itself consists of three main components—canned tuna, mayonnaise and some sort of ingredient…

A look at what stocks Ackman was buying the first quarter of 2020 Continue reading...

Agilent Technologies Inc. shares rose 3% in the extended session Thursday, after the company topped earnings and revenue expectations. Agilent reported second-quarter net income of $101 million, which amounts to 32 cents a share, compared with $182 million, or 57 cents a share, in the year-ago period. Adjusted for asset impairments, intangible amortization, among other items, earnings were 71 cents a share. Revenue was flat at $1.24 billion. Analysts polled by FactSet expected adjusted earnings of 61 cents a share on revenue of $1.21 billion. In a statement, Agilent Chief Executive Mike McMullen said that the company is well-positioned to "face the challenges" of the COVID-19 pandemic and the company was poised to focus on "growth, a resilient business model, and strong balance sheet, and most importantly, our outstanding team." Agilent stock has fallen 5.1% this year, as the S&P 500 index dropped 8%.

If you received a stimulus check made out to a deceased relative, or a direct deposit into one of their accounts that you control or even if you and a deceased spouse received a joint stimulus payment, the IRS is requesting that you return the money (or half …

Agilent's (A) second-quarter fiscal 2020 results reflect negative impact of coronavirus outbreak despite robust performance of the Diagnostics and Genomics Group.

Most of us have been home with our kids for at least a month. My kids have been home since March 6 (but who’s counting?), and although we are happy to keep our distance as long as necessary, I desperately long for the days when I could drop my girls off with …

The online retailer and cloud giant is pouring millions into a developing a way to test its front-line workers. That has one analyst dreaming of Amazon as a force in testing.

Canned corn is not and never will be as good as the fresh stuff—which, thankfully, is just coming in season—but I still keep a few cans around just in case I experience an emergency that calls for either corn casserole or a quick pickled corn. It is admittedl…

Activist investor releases 1st-quarter portfolio Continue reading...

Herbaria make fascinating time capsules. In a museum or university near you, there’s probably a room with pages and pages of old, large sheets of paper, each with a dried whole plant delicately taped to it. These are the plant equivalents of dinosaur bones or…

Never booked a flight before? Look, we’ve been there. Maybe someone else has always done it for you. Maybe you’re just out of college and your parents always made the travel arrangements. Or you’ve just… never flown before.Read more...

Their earnings per share growth rate topped the S&P; 500 over the past five years Continue reading...

Q2 2020 Agilent Technologies Inc Earnings Call

Health-care stocks that were popular in ESG funds tended to score better on ESG issues than other stocks in the sector in conventional funds, according to a study.

Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In the event that your pet needs medical care, what do you do? As with so many other aspects of life during a pandemic, getting veterinary care for your pet is a rapidly changing situation, one for which vets across the country have adapted. Read more...

Agilent to present at Jefferies Virtual Healthcare Conference.

I have found there is an ebb and flow to parenting during a pandemic. It has played out in my own home, as well as across my social media feeds, and it goes a little something like this: “Omg, the kids are on screens way too much! They need more educational a…

International travel involves a lot of moving parts:from getting a passport and booking your itinerary to budgeting your trip and learning the basics of the language and local customs. An additional component you may need to figure out is whether or not you n…

As businesses reopen and people take to the beaches and parks, you’ve probably seen news photos or video that appear to show people packed into dense crowds, blithely ignoring social distancing guidelines. But these photos can be misleading, and it’s thanks t…

During an unprecedented rise in unemployment, there is increasing demand for one job: contact tracers. Part of the Centers for Disease Control’s multipronged response to the COVID-19 pandemic, contact tracing involves calling people with suspected and confirm…

Agilent announces dividend of 18 cents per share.

As rules relax, we must ask ourselves some strange questions: Is it safe to see a friend? Go to the park? Eat in a restaurant? No matter how many experts you ask, there’s not going to be a clear yes-or-no answer. Read more...

Shares in Agilent Technologies (A) rose 5% on Friday after the company reported revenue of $1.24B which beat Street estimates by $40M and came in flat on a year-over-year (y/y) basis.Q2 Non-GAAP EPS of $0.71 beat consensus by $0.10, although GAAP EPS of $0.32 misses by $0.17. The stock is now down 0.4% since the beginning of the year.Operating profit rose 2.2% y/y to $277M, while core revenue declined 1.7% y/y, reflecting the impact of Covid-19 business disruption (particularly within academic & government and chemical & energy end-markets).“Our business was tracking well into late March when we experienced significant disruption in the U.S. and Europe as customers closed or restricted access to their facilities to slow the spread of COVID-19,” said Mike McMullen, Agilent president and CEO.“I believe we are well-positioned to face the challenges brought on by COVID-19 given our focus on growth, a resilient business model, a strong balance sheet, and most importantly, our outstanding team” he added.Following earnings, Needham’s Stephen Unger reiterated his Hold rating without a price target. “Considering the COVID-19 environment, A’s FY2Q20 results were solid with adj. EPS growing 0.6% y/y to $0.71 – $0.04 below our model” he wrote.As a result, the analyst lowered his FY20 adj. EPS estimate from $3.42 to $3.02 (3% decline from FY19) on revenues of $5.122B (1.8% core revenue decline), a $388M reduction from his previous forecast.“Given increased downside potential associated with business disruption from the COVID-19 pandemic, we consider the lower half of the [stock’s current] trading range to approximate fair value ($79.00-89.00)” Unger told investors on May 22.Indeed, the majority of analysts covering A rate the stock a hold, with 7 recent hold ratings vs 4 buy ratings. The $89 average analyst price target indicates upside potential of 5%.  (See Agilent stock analysis on TipRanks)Related News: Gilead and Galapagos Score Positive Topline Results For Ulcerative Colitis Trial Moderna Spikes 21% Amid “Positive” Early-Stage Covid-19 Vaccine Data AstraZeneca-Merck Lynparza Prostate Cancer Treatment Gets FDA Approval More recent articles from Smarter Analyst: * Google Pay App May Face Anti-Trust Probe In India – Report * Trump Threatens Twitter After It Labels His Tweets "Potentially Misleading" * General Electric Surges 8% Amid Sale Of Lighting Unit To Savant   * Gilead & Arcus Join Forces For 10-Year Cancer Deal, Arcus Down 15% In Pre-Market

Agilent Technologies Inc. (NYSE: A) announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge, Massachusetts. LabCentral is a shared laboratory space designed as a launchpad for high-potential life sciences and biotech startups. The Golden Ticket provides funding of one lab bench space for a year.